The first six articles in this series traced one direction: backward, from a 2026 portfolio to the 2017 notebook that seeded it. This last article points the other way. What is still in the book and not yet built. What I am working on now. Where I think the existing intellectual property is most useful. And what the portfolio is honestly worth. This is the shortest article in the series, and the most forward-looking.

What’s still in the book

Of the 1,739 entries in Invent Depositions, roughly thirty percent have been developed into one of the forty-eight projects. The other seventy percent — more than a thousand dated, patent-pending disclosures — are still sitting in the book as undeveloped depositions, each one waiting for the time, the capital, or the market signal that would justify building it out.

A few clusters are worth naming, because they are the most likely next projects:

• Medical and biotech — about fifty-two entries, only partially productized through the FDA-pathway projects. This is the cluster with the largest gap between what is disclosed and what is built.
• Recycling and environment — about fifty-eight entries. The chemical cooker and the landfill projects are live; most of the cluster is not.
• Communications — about two hundred and twenty-six entries, of which only the NewStar Cell and the Communications Satellite have become projects. This is the largest under-productized cluster in the book by raw count.
• Consumer products — many entries, almost none built. The barrier here is not invention; it is the cost and risk of consumer manufacturing.
• The handheld optical-cavity device — the consumer-scale version of the Project 48 architecture, working name AutoPhi Flash. It is identified and specified at the architecture level but is not yet its own project.

I mention these not as promises but as a map. The seventy percent is the inventory the next decade draws from.

What I’m working on privately

I will not disclose past the point that is prudent before a disclosure date, but I can name the directions without naming the details:

• A synthetic chromophore for the Project 48 energy cell — chemistry refinement on the light-absorbing layer.
• A tunable phosphor stack for the thermoelectric backside of that same cell — materials science on waste-heat recovery.
• The next voxel-processor architecture beyond the current generations.
• A further set of mathematical depositions covering recursive growth bounds and additional kernel variants.
• A consumer-electronics line built on the voxel architecture, not yet specified publicly.

Each of these will, in time, follow the same path everything else in the portfolio followed: disclosed first, dated, marked patent-pending, then elaborated and productized as the situation allows.

Where the existing IP is most useful

If you work in one of these industries, the existing, already-disclosed portfolio is where I think it maps most directly:

• Solar power generation — the laser-solar building architecture (Project 48) and its handheld and utility-scale variants.
• Integrated circuit design — the voxel-processor architecture (the AutoPhi computing family).
• Sovereign-money and civic-identity infrastructure — the government-inventions collection (Project 47).
• Medical device development — the disease-discovery and health-recovery clusters.
• Recycling and waste-to-energy — the microwave-recycling and chemical-cooker projects.

I list these so you can self-select. If your work is in one of these areas, there is dated IP here that may save you years of priority. If it is not, the catalog is large enough that there may still be something — but these five are where the fit is clearest.

What the portfolio is worth

I want to be honest about this rather than dramatic, because the headline numbers invite drama.

The aggregate catalog valuation across all forty-eight projects, computed from the per-deposition valuation models, lands in the multiple-trillions range, dominated by the AutoPhi Omega Collection. I will tell you exactly what that figure is and is not. It is a catalog valuation — a model output, depositions multiplied by a per-deposition value — and an estimated ask. It is not an appraisal, it is not a transaction price, and no one has paid it. The realistic transaction pricing for individual projects is in the range of millions to billions, depending on the scale of the invention and the licensing tier. That is the number a serious buyer should hold in mind. The trillion-scale figure is the model’s view of the whole; the millions-to-billions figure is what a real deal looks like.

I would rather state that plainly and lose the headline than let a buyer think the storefront number is a price tag. It is not. The price is a conversation.

How to engage

Everything serious goes through info@cri-one.com. An NDA is required before any technical disclosure beyond what is already public in the 2017 book — which, to be clear, is a great deal; the book itself is still in print, still available under ISBN 9781979767897, and still the best free introduction to the whole portfolio. Acquisitions are bespoke. There is no retail path to the IP, and I do not want there to be.

Closing

Thank you for reading this far. Seven articles is a lot to ask of anyone’s attention, and I am grateful for it.

The case I have tried to make across this series is simple, even if the portfolio is not. In 2017 I could not afford to file patents on a thousand inventions, so I did the next best thing: I wrote them all down, dated them, marked them, and published them in a book anyone could buy. For nine years that book has done exactly what I built it to do. It secured priority on things I knew were valuable and on things I had no idea would be — the sixteen-digit card, the voxel architecture, the laser-solar building — and it let the future, rather than my own guesswork, decide which ones mattered.

That is the whole strategy. Disclose broadly. Date everything. Build the winners as they reveal themselves. I am more optimistic about the next decade of this portfolio than I was about the last, because the foundation is already in the ground and already nine years old. The harvest is still ahead.

If any of it is useful to you, I would like to hear from you.

Christopher Gabriel Brown is the founder of cri-one.com and the author of Invent Depositions (ISBN 9781979767897). This concludes the series From a 2017 Notebook to a 2026 Portfolio — index: SERIES_INDEX.md.